CytoMed Therapeutics Limited Employee Benefits Expense
CytoMed Therapeutics Limited (GDTC) reported Employee Benefits Expense of SGD 930.56 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:EmployeeBenefitsExpense · last filed 2026-03-31
SGD
| Period end | Employee Benefits Expense 12 month |
|---|---|
| 2025-12-31 | 930.56K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 619.33K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 454.14K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 210.66K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 168.80K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 130.99K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Employee Benefits Expense 12 month |
|---|---|
| 2025-12-31 | $723.67K 20-F · filed 2026-03-31 |
| 2024-12-31 | $453.32K 20-F · filed 2025-04-28 |
| 2023-12-31 | $344.23K 20-F · filed 2024-04-22 |
| 2022-12-31 | $157.16K 20-F · filed 2023-05-01 |